CLOV - Company ID 0001801170
The table below shows CLOVER HEALTH INVESTMENTS, CORP. /DE's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $749.19M | $496.65M | $477.62M | $462.33M | $330.99M | $356.26M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | $81.21M | $107.91M |
| R&D | - | - | - | - | - | - |
CLOVER HEALTH INVESTMENTS, CORP. /DE reported annual revenue of $1.92B for fiscal year 2025. That is up 40.3% from $1.37B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $462.27M (FY 2019) to $1.92B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $74.63M |
| $48.95M |
| $48.48M |
| $50.67M |
| $35.20M |
| $44.42M |
| Operating income | $27.33M | -$24.38M | -$10.56M | -$1.27M | -$8.79M | $7.19M |
| Income tax | - | - | - | - | - | - |
| Net income | $27.33M | -$24.38M | -$10.58M | -$1.27M | -$9.15M | $7.41M |
| EPS (diluted) | $0.05 | - | - | $0.00 | - | - |